CD8A and neoplasm: Of the three cell lines used in this study, MC38 tumor cells have the highest mutational burden (45) with several MC38-specific neoantigens that can be presented by MHC-I on MC38 tumor cells and recognized by antigen-specific CD8+ T cells (46).